the nurse is administering an ace inhibitor to a client what is the most common side effect

ATI RN

Cardiovascular System Practice Exam

1. The nurse is administering an ACE inhibitor to a client. What is the most common side effect?

A. Cough
B. Dizziness
C. Hypotension
D. Hyperkalemia

Correct answer: A

Rationale: The correct answer is A: Cough. Cough is a well-known side effect of ACE inhibitors due to an increase in bradykinin levels. This irritating cough can be bothersome to clients and should be monitored. Choice B, Dizziness, is not the most common side effect of ACE inhibitors. While ACE inhibitors can cause hypotension (Choice C), cough is more prevalent. Hyperkalemia (Choice D) is a possible side effect of ACE inhibitors but is less common compared to cough.

2. What is the approximate stroke volume of the heart?

A. Approximately 60 mL of blood per beat
B. Approximately 70 mL of blood per beat
C. Approximately 80 mL of blood per beat
D. Approximately 90 mL of blood per beat

Correct answer: B

Rationale: The correct answer is B: Approximately 70 mL of blood per beat. The stroke volume of the heart is typically around 70 mL, indicating the volume of blood ejected from the left ventricle with each contraction. Choices A, C, and D are incorrect as they do not represent the standard approximate stroke volume of the heart, which is around 70 mL per beat.

3. The client on warfarin has an INR of 1.2. What is the nurse’s priority action?

A. Increase the dose of warfarin
B. Administer vitamin K
C. Monitor for signs of bleeding
D. Hold the next dose and notify the healthcare provider

Correct answer: A

Rationale: The correct answer is to increase the dose of warfarin. An INR of 1.2 is below the therapeutic range for a client on warfarin, indicating that the dose is subtherapeutic. The priority action in this situation is to adjust the dose to achieve the target therapeutic INR range (usually 2-3) to prevent thromboembolic events. Administering vitamin K is not necessary as the INR is low, and there are no signs of bleeding. Monitoring for signs of bleeding is important but not the priority in this case since the INR is subtherapeutic. Holding the next dose and notifying the healthcare provider would delay the intervention needed to adjust the dose and achieve the therapeutic range.

4. The client is given an alpha agonist. What might it be used for?

A. For hemostasis
B. To dilate the arteries
C. To dilate the veins
D. To decrease afterload

Correct answer: A

Rationale: Alpha agonists are used for hemostasis to help control bleeding by constricting blood vessels, leading to decreased blood flow to the area. Choices B, C, and D are incorrect as alpha agonists do not typically dilate arteries, dilate veins, or decrease afterload.

5. Which condition is characterized by the right ventricle of the heart failing due to increased pressure in the lungs, often caused by chronic lung disease?

A. Cor pulmonale
B. Pulmonary embolism
C. Aortic stenosis
D. Hypertrophic cardiomyopathy

Correct answer: A

Rationale: The correct answer is Cor pulmonale, a condition where the right ventricle of the heart fails due to increased pressure in the lungs, commonly caused by chronic lung diseases like COPD. Pulmonary embolism (choice B) is a blockage in one of the pulmonary arteries in the lungs, usually caused by a blood clot. Aortic stenosis (choice C) is a narrowing of the aortic valve opening that restricts blood flow from the left ventricle to the aorta. Hypertrophic cardiomyopathy (choice D) is a genetic condition where the heart muscle becomes abnormally thick, making it harder for the heart to pump blood.